Influence of orally administered bovine lactoferrin on lipid metabolism in lipopolysaccharide-injected preruminant calves. 2009

Shiro Kushibiki, and Hiroyuki Shingu, and Tokushi Komatsu, and Fumiaki Itoh, and Naoko Moriya, and Eiko Touno, and Akinori Oshibe, and Koichi Hodate
Department of Animal Physiology and Nutrition, National Institute of Livestock and Grassland Science, Tsukuba, Japan. mendoza@affrc.go.jp

ABSTRACT The aim of this study was to investigate the influence of oral lactoferrin (LF) administration on lipid metabolism changes in calves given lipopolysaccharide (LPS). Twenty-one 4-day-old Holstein calves were divided into three groups, with each group receiving one of three oral doses of LF (0, 1, 3 g/day) for 10 consecutive days (day -10 to day -1). All calves were intravenously injected with LPS (50 ng/kg BW) on day 0, the day after LF treatment ended. Plasma triglyceride concentrations were lower (P < 0.05) in the LF-treated calves than in the control calves given 0 g/day of LF at 12 and 24 h after LPS injection. Plasma NEFA concentrations were elevated between 6 and 24 h after LPS treatment. At 12 h, the concentration of plasma NEFA was lower (P < 0.05) in the calves given LF 3 g/day than in the control calves. On day 0, plasma total cholesterol and phospholipid concentrations tended to be lower in the LF groups administered 1 and 3 g of LF/day than in the control group, but did not differ significantly among the groups. The plasma very-low-density and low-density lipoprotein concentrations were lower (P < 0.05) at 12, 24, and 72 h in the LF groups than in the control calves. The concentrations of plasma high-density lipoprotein tended to be lower in the LF groups than in the control group between day 0 and 96 h, though there were no significant group differences. The concentration of plasma interleukin-1beta was lower (P < 0.05) in the calves fed LF 3 g/day than in the control calves at 2 and 12-48 h after LPS injection. These data suggest that LF inhibits LPS-induced alterations in lipid metabolism in preruminant calves.

UI MeSH Term Description Entries
D007781 Lactoferrin An iron-binding protein that was originally characterized as a milk protein. It is widely distributed in secretory fluids and is found in the neutrophilic granules of LEUKOCYTES. The N-terminal part of lactoferrin possesses a serine protease which functions to inactivate the TYPE III SECRETION SYSTEM used by bacteria to export virulence proteins for host cell invasion. Lactotransferrin
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D050356 Lipid Metabolism Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS. Metabolism, Lipid

Related Publications

Shiro Kushibiki, and Hiroyuki Shingu, and Tokushi Komatsu, and Fumiaki Itoh, and Naoko Moriya, and Eiko Touno, and Akinori Oshibe, and Koichi Hodate
January 1998, Advances in experimental medicine and biology,
Shiro Kushibiki, and Hiroyuki Shingu, and Tokushi Komatsu, and Fumiaki Itoh, and Naoko Moriya, and Eiko Touno, and Akinori Oshibe, and Koichi Hodate
July 1987, The veterinary quarterly,
Shiro Kushibiki, and Hiroyuki Shingu, and Tokushi Komatsu, and Fumiaki Itoh, and Naoko Moriya, and Eiko Touno, and Akinori Oshibe, and Koichi Hodate
November 1995, Applied and environmental microbiology,
Shiro Kushibiki, and Hiroyuki Shingu, and Tokushi Komatsu, and Fumiaki Itoh, and Naoko Moriya, and Eiko Touno, and Akinori Oshibe, and Koichi Hodate
January 1998, Advances in experimental medicine and biology,
Shiro Kushibiki, and Hiroyuki Shingu, and Tokushi Komatsu, and Fumiaki Itoh, and Naoko Moriya, and Eiko Touno, and Akinori Oshibe, and Koichi Hodate
August 2005, Journal of medical microbiology,
Shiro Kushibiki, and Hiroyuki Shingu, and Tokushi Komatsu, and Fumiaki Itoh, and Naoko Moriya, and Eiko Touno, and Akinori Oshibe, and Koichi Hodate
November 1990, Journal of dairy science,
Shiro Kushibiki, and Hiroyuki Shingu, and Tokushi Komatsu, and Fumiaki Itoh, and Naoko Moriya, and Eiko Touno, and Akinori Oshibe, and Koichi Hodate
January 1993, Bioscience, biotechnology, and biochemistry,
Shiro Kushibiki, and Hiroyuki Shingu, and Tokushi Komatsu, and Fumiaki Itoh, and Naoko Moriya, and Eiko Touno, and Akinori Oshibe, and Koichi Hodate
January 2001, International journal of cancer,
Shiro Kushibiki, and Hiroyuki Shingu, and Tokushi Komatsu, and Fumiaki Itoh, and Naoko Moriya, and Eiko Touno, and Akinori Oshibe, and Koichi Hodate
June 2004, Journal of medical microbiology,
Shiro Kushibiki, and Hiroyuki Shingu, and Tokushi Komatsu, and Fumiaki Itoh, and Naoko Moriya, and Eiko Touno, and Akinori Oshibe, and Koichi Hodate
January 2000, BioFactors (Oxford, England),
Copied contents to your clipboard!